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Biochemistry, University of Michigan, Ann Arbor, MichiganABSTRACT Soluble oligomers of the amyloid-b peptide have been implicated as proximal neurotoxins in Alzheimer’s disease.
However, the identity of the neurotoxic aggregate(s) and the mechanisms by which these species induce neuronal dysfunction
remain uncertain. Physiologically relevant experimentation is hindered by the low endogenous concentrations of the peptide, the
metastability of Ab oligomers, and the wide range of observed interactions between Ab and biological membranes. Single-mole-
cule microscopy represents one avenue for overcoming these challenges. Using this technique, we find that Ab binds to primary
rat hippocampal neurons at physiological concentrations. Although amyloid-b(1–40) as well as amyloid-b(1–42) initially form
larger oligomers on neurites than on glass slides, a 1:1 mix of the two peptides result in smaller neurite-bound oligomers
than those detected on-slide or for either peptide alone. With 1 nM peptide in solution, Ab40 oligomers do not grow over the
course of 48 h, Ab42 oligomers grow slightly, and oligomers of a 1:1 mix grow substantially. Evidently, small Ab oligomers
are capable of binding to neurons at physiological concentrations and grow at rates dependent on local Ab42:Ab40 ratios. These
results are intriguing in light of the increased Ab42:Ab40 ratios shown to correlate with familial Alzheimer’s disease mutations.INTRODUCTIONAlzheimer’s disease (AD), the sixth leading cause of death
in the United States, is characterized by the development
of extracellular plaques composed of fibrils of amyloid-
b peptide (1). In recent years, emerging evidence has caused
the amyloid cascade hypothesis (which implicates plaques
in AD neurotoxicity) to be largely supplanted by an amyloid
oligomer hypothesis (2). This concept presents small
amyloid-b oligomers as the synaptotoxic molecular struc-
tures that lead to AD. Amyloid-b is a 39-to-43 residue
peptide produced by b- and g-secretase cleavage of an inte-
gral membrane protein, amyloid-precursor peptide (3).
Many of the ~10% of AD cases that are genetic in nature
(familial Alzheimer’s disease, or FAD) are correlated with
mutations in presenilin, the catalytic subunit of g-secretase.
Such mutations frequently increase the ratio of Ab42/Ab40,
which may contribute strongly to AD development in these
patients (3,4).
Ab is present in both normal and AD human brain tissue
at subnanomolar to low nanomolar concentrations (5,6). At
these low concentrations, the oligomeric state of the peptide
is thought to be in a constant state of flux, with small aggre-
gates (monomers to hexamers) interconverting in a dynamic
equilibrium (7–9). These factors complicate attempts to use
existing data to draw conclusions about actual conforma-
tional and stoichiometric states of Ab in the human brain.Submitted August 5, 2012, and accepted for publication December 18, 2012.
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0006-3495/13/02/0894/10 $2.00Numerous specific components of the lipid bilayer have
been implicated as Ab-binding sites through which toxicity
might be mediated. These include externalized phosphati-
dylserines (10,11), GM1 ganglioside containing micro- or
nanodomains (12,13), and regions with increased choles-
terol content (14). However, substantial evidence has also
been put forth for protein receptors as probable Ab-binding
sites (15), including a-7 nicotinic acetylcholine receptors
(a7nAchRs) (16), the cellular prion protein (PrPC) (17),
metabotrobic glutamate receptor 5 (mGluR5) (18), and
EphB2 receptors (19). Most of these integral membrane
protein receptors for Ab have been proposed in an effort
to explain the peptide’s well-documented effects on synaptic
plasticity. Although they provide interesting directions for
future study, these experiments have generally been per-
formed in model mouse systems, at higher than physiolog-
ical Ab concentrations, or using Ab oligomers prepared
in vitro.
Several distinct subfibrillar Ab aggregates isolated in
laboratory settings have been characterized and may
contribute to AD neurotoxicity. These include low-n oligo-
mers such as sodium dodecyl sulfate (SDS)-stable dimers,
trimers, and tetramers, ADDLs (amyloid-derived diffusible
ligands), the Ab*56 dodecameric oligomer, AbOs, ASPDs
(SDS-stable amylospheroids), and APFs (annular protofi-
brils) (20). The role of membrane interactions in the forma-
tion of these toxic Ab oligomers is a subject of particularly
strong debate. A number of groups have found that preag-
gregated Ab induces greater toxicity than monomeric or
fibrillar Ab, implying that oligomers formed in solution
without contact with biological membranes must be capablehttp://dx.doi.org/10.1016/j.bpj.2012.12.051
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ever, treatment of biological membranes with unaggregated
Ab is also associated with toxicity, more specifically with
formation of cation-selective pores as evidenced by step-
wise membrane conductance changes (23,24).
The wide variation in observed binding sites and
proposed oligomer structure reflects fundamental uncer-
tainties in the field regarding how Ab oligomers form,
interact with membranes, and behave following binding.
Recently, Zhang and associates used surface pressure
measurements to determine the relative abilities of mono-
meric Ab, ADDLs, and protofibrillar Ab to insert into planar
membranes (25). Monomers of the peptide inserted into the
membrane more rapidly than oligomers of either type and
oligomerized, following binding, in a process distinct
from oligomerization in solution. Zhang et al. (25) proposed
that intramembrane and extramembrane oligomerization
may produce two separate pools of Ab whose toxicities
are mediated by completely distinct mechanisms. Oligo-
mers formed in the membrane may directly disrupt
membrane integrity by transient pore formation, allowing
toxic calcium influx. At the same time, oligomers formed
in solution may, as previously discussed, interact with
specific cellular receptors, altering their function and result-
ing in toxicity. Of importance, at physiological concentra-
tions, any toxicity induced by binding of monomeric
peptide and subsequent formation of oligomers likely
occurs gradually. For example, Shankar and colleagues
(26) demonstrated significant immediate drops in long-
term potentiation with application of dimers isolated from
human brain at subnanomolar levels. However, little
decrease in long-term potentiation was observed with appli-
cation of synthetic, initially monomeric Ab40 at concentra-
tions below 50–100 nM. Our own recent work showed that
application of 50 nM monomeric Ab40 induces only very
subtle leakage of calcium into SH-SY5Y cells, though on-
membrane oligomer formation occurs within minutes (27).
However, the low concentration regime still represents an
important area of study. Understanding the mechanics of
amyloid-b’s interactions with membranes at physiological
concentrations, before the induction of grossly observable
toxicity, may be necessary for the development of targeted
neuroprotective therapy.
Our group has recently used single-molecule microscopy
to study the size distributions of Ab aggregates generated at
physiological concentrations in solution (9), on planar
model membranes (28), and on living SH-SY5Y neuroblas-
toma cells (27). Single-molecule microscopy provides
several advantages for the study of this system. Experiments
can be performed at low concentrations to more closely
simulate peptide concentrations in the brain. Dynamics of
rapidly shifting oligomer populations and the motion of
individual particles can be easily monitored over time.
Single oligomers that might be lost in an ensemble measure-
ment can be resolved and potentially associated withspecific binding locations. These properties combine to
make single-molecule techniques uniquely well suited for
studies of Ab-membrane interactions.
Here, we show that single-molecule microscopy of
HL647Ab is feasible on the processes of primary hippo-
campal neurons in culture. We show that Ab binds to
neurites at physiological peptide concentrations within
minutes and that these early oligomers do not preferentially
bind to synapses. Interestingly, the binding and evolution of
oligomers on neurites is strongly affected by the stoichiom-
etry of Ab40 and Ab42 peptides. Initial neurite-bound
HL647Ab40 and HL647Ab42 oligomers are shown to be
larger than those bound nonspecifically to coverslips, but
undergo little growth over the course of additional 48-h
incubation. A 1:1 mix of the two peptides, however, initially
appears on neurites as very small oligomers, but these grow
substantially over the next 2 days. Our results imply that
localized increases in the Ab42:Ab40 ratio, independently
of changes in overall Ab concentration, significantly alters
the kinetics of on-membrane oligomer growth.METHODS
Peptide preparation
Synthetic unlabeled amyloid-b(1–40), N-terminally HiLyte Fluor 647-
labeled amyloid-b(1–40), and (1–42) (HL647Ab40 and 42, respectively),
and HiLyte Fluor 647 hydrazide were obtained from Anaspec
(Freemont, CA). Amyloid-b (Ab) peptides were dissolved in 1% NH4OH
at 0.1 mg/mL and vortexed for 30 s to mix. Peptides were lyophilized
and stored at 20C. To prepare fresh Ab samples, single aliquots were
dissolved in 10 mM sodium phosphate buffer, pH 7.4, at 1 to 2 mM, and
pipetted 5 to 8 times to mix. Freshly prepared Ab was used within 1 h.
For spin-coated sample preparation, freshly solubilized HL647Ab40 or
HL647Ab42 was diluted to 0.5 nM in 10 mM sodium phosphate, pH 7.4,
and 100 mL of this was spin-coated onto a kilned glass slide.Primary rat hippocampal cell culture
Primary rat hippocampal neuron cultures were prepared as described (29).
Cells were plated at 30,000/well on 14 mm poly-D-lysine coated glass
coverslips adhered to 35 mm culture dishes (MatTek, Ashland, MA).
Imaging experiments were performed between DIV 12 and DIV 18. For
single molecule oligomer size measurement experiments, cells were incu-
bated for 10 min at 37C in HBS (HEPES-Buffered Saline: 119 mM
NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 mM
HEPES, pH 7.4) containing 1 nM HL647Ab, washed three times in
HBS, and imaged at room temperature in HBS within an hour of exposure.
For time course experiments, following initial incubation with 1 nM
HL647Ab, cells were placed back in the original media containing either
no Ab or 1 nM Ab and incubated at 37C for the time specified. Immedi-
ately before imaging, cells were washed three times in HBS and then
imaged within an hour.Fluorescence lifetime measurements
Fluorescence lifetimes of HL647 hydrazide, HL647Ab40, and HL647Ab42
were assessed using the Time-Resolved Confocal Microscope ALBA
System (Champaign, IL) at the University of Michigan SMART (single
molecule analysis in real time) Center. Fitting the resulting decay curvesBiophysical Journal 104(4) 894–903
896 Johnson et al.yielded fluorescence lifetimes of 1.538 5 0.009 ns for the HL647
hydrazide free dye, 1.646 5 0.002 ns for the HL647Ab40, and 1.688 5
0.004 ns for the HL647Ab42. The slightly increased lifetimes of the dye
when bound to the peptide likely reflect slight changes to the local
electronic environment. As these lifetimes are not equivalent within exper-
imental error, the HL647 hydrazide fluorescence intensity per monomer
was multiplied by 1.0702, the ratio of tHL647AB40/tHL647, obtain expected
intensity per HL647Ab40 monomer. For HL647Ab42, the correction ratio
(ratio of tHL647AB42/tHL647) was 1.0974, and for experiments with a 1:1
mix of the two peptides, the average of the two ratios, 1.0838, was used
to determine expected monomer intensity.FIGURE 1 Amyloid-b(1–40) binds to primary rat hippocampal neurites
with high affinity. Very densely bound oligomers are visible on neurites
treated for 10 min with 50 nM HL647Ab40 (top left image, scale barConfocal mode integrated intensity-based
oligomer size determination
We recently used confocal mode fluorescence intensity to measure olig-
omer size on black lipid membranes (28). To measure oligomer size on
living cells, we developed a protocol to correlate particles’ confocal
mode fluorescence intensity values with the number of Ab monomers
they contain (27). When laser power is below saturation, the fluorophore
emission varies linearly with excitation power. Under these conditions,
the slope of total intensity from a given volume versus the number of mole-
cules present in the volume yields intensity per molecule. The fluorescence
intensity of an oligomer can be divided by this value to yield the number of
Ab monomers present in the oligomer (assuming the quantum yields of the
free dye and peptide-bound dye are the same). Single oligomer size
measurements were performed here as described (27) (also see the Support-
ing Material). Briefly, primary cultures were imaged within 1 h of removal
from incubators. Cell-bound oligomers were defined as those fluorescence
spots whose maxima fell on or within 500 nm of a neurite and were boxed
with a 40 pixel 40 pixel (~1.6 mm 1.6 mm) region of interest. Following
subtraction of background fluorescence counts, the integrated fluorescence
intensity of each region of interest was divided by fluorescence intensity per
molecule to determine oligomer size.10 mm). Single oligomers are detected on neurites treated with 1 nM
HL647Ab40 (middle image, scale bar 5 mm), but not on neurites treated
with 1 nM unlabeled Ab40 as a control (bottom image, scale bar 5 mm).
Analysis of 20 frames of neurites in each 1 nM-treated sample (right
plot) yielded 237 single particles in HL647Ab40-treated neurites (black
bars), but only two particles with intensity equivalent to monomers in unla-
beled Ab40-treated neurites (hatched bar).RESULTS
Single HL647Ab40 oligomers bind to primary
rat hippocampal neurites
In preliminary experiments for the study of single Ab olig-
omers on neurites, primary rat hippocampal cultures were
exposed to 50 nM HL647Ab40 for 10 min and imaged at
single-molecule sensitivity. HL647Ab40 bound strongly to
neurites at this concentration (top left image, Fig. 1), at
too high a density for detection of individual oligomers.
Optimal binding densities for single-molecule detection
were obtained at a concentration of 1 nM (middle left image,
Fig. 1). Of note, in multiple preliminary experiments assess-
ing calcium leakage, grossly observable changes in calcium
transient frequency and spine density over an hours-to-days
timescale, Ab treatment at concentrations <10 nM pro-
duced no significant toxicity compared to controls. To
ensure that starting material contained unaggregated
peptide, single-molecule photobleaching experiments were
performed on dry spin-coated samples of freshly prepared
HL647Ab40 and HL647Ab42, as in our previous work
with live cells (27). Over 90% of single peptide species
in these samples bleached as monomers, with the vast
majority of the remainder bleaching as dimers (Fig. S1 inBiophysical Journal 104(4) 894–903the Supporting Material). Confocal integrated intensity olig-
omer size measurement was also verified by comparison
with the single-molecule photobleaching method for
HL647Ab42, as was done for labeled Ab40 in our previous
work (Fig. S2) (27). Comparison of oligomer size
histograms from 20 images acquired in cultures treated
with unlabeled Ab40 (bottom left image, Fig. 1) and
HL647Ab40 reveals that autofluorescence is minimal in
these samples (plot at right, Fig. 1). In 20 images from
the unlabeled Ab40 sample, only two particles with bright-
ness equivalent to monomers were detected. A total of
237 particles with fluorescence intensity ranging from
monomer equivalent to octamer equivalent were detected
in 20 HL647Ab40 images. These results confirmed that
primary rat hippocampal neurites treated briefly with
HL647Ab40 and HL647Ab42 represented a suitable system
for single-molecule study of Ab oligomer membrane
binding and growth.
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larger than slide-bound oligomers
Our earlier results indicate that Ab40 binds rapidly to living
cells and forms larger oligomers on the membranes of these
cells than on the glass coverslips to which the cells are
adhered (27). Results on neurites were consistent with this
earlier observation: oligomers again bound both to slides
and to cell membrane at the peptide concentrations used
for the study (Fig. S3). Raw oligomer size distributions
for HL647Ab40 and HL647Ab42 oligomers detected on
neurites were significantly shifted toward larger particles,
as compared to the distributions obtained for slide-bound
oligomers (Mann-Whitney U-test, p < 0.00001 for both
Ab40 and Ab42). On-slide HL647Ab40 and HL647Ab42
oligomers had an average size of 1.4 peptide subunits,
whereas the average respective neurite-bound oligomer
sizes were 2.2 and 1.9 peptide subunits. As seen in Fig. 2,
for both Ab40 and Ab42 oligomers detected on-slide,
monomers comprised the largest reservoir of peptide,
containing 45% to 50% of the total. However, for Ab40FIGURE 2 Ab40 and Ab42 oligomers on neurites are larger than those
on slides. Distributions are shown as percentage of total peptide present
within each oligomer population for HL647Ab40 (top) and HL647Ab42
(bottom), nonspecifically bound to slides (black) or bound to primary rat
hippocampal neurites (cross-hatched). Proportions were calculated using
compiled data from three separate experiments, 20 images each. Each
sample contains at least 1600 peptide subunits present in a minimum of
750 particles. Error bars represent standard error of the percentage.and Ab42 on neurites, dimers contained the highest propor-
tion, respectively 36% and 43% of the total peptide.
A number of groups have observed that Ab oligomers
localize to synapses (18,30,31). To determine whether the
small HL647Ab40 and HL647Ab2 oligomers we observe
on neurites bind preferentially to synapses, neurites treated
with 5 nM peptide were stained for PSD-95, a postsynaptic
membrane marker protein, or for Ab (as a positive control)
(Fig. S4). Although significant colocalization is observed
between HL647Ab and anti-Ab antibody on neurites
(Fig. S4), comparatively little overlap is visible between
PSD-95 and HL647Ab40 or HL647Ab42. This indicates
that small oligomers formed at physiological concentrations
of HL647Ab on neurites do not preferentially bind to
synapses, at least initially. The difference between this
observation and that of previous studies (18,30,31) is
addressed in the Discussion. Briefly, one explanation for
this result might be that Ab binds to a pre- or postsynaptic
receptor molecule that is predominantly present at the
synapse only under certain conditions. Therefore, if a
substantial portion of the proposed Ab receptor population
were extrasynaptic under our experimental conditions,
bound Ab might not appear to colocalize with synapses.
Depending on whether the targeted receptor is presyn-
aptic or postsynaptic, it could be expected to be expressed
at a higher density on axons than on dendrites or vice versa.
In fact, surface density of certain posited Ab receptors or
target proteins has been shown to be site-specific, with
mGluR5, NMDA receptors, and cellular prion protein all
more strongly concentrated on dendrites or at the postsyn-
aptic membrane than on axons (17,32,33). Measurement
of the number of receptors per unit length would include
both extrasynaptic and intrasynaptic populations. Therefore,
we hypothesized that if a substantial portion of the Ab
receptor population were extrasynaptic, and Ab binds to
a postsynaptic receptor, Ab would bind more densely on
dendrites than on axons. To test this, we assessed bound
oligomer density on neurites treated with 5 nM HL647Ab
and then stained with specific markers for axons and
dendrites and binding density per unit length was measured.
The values were compared to determine whether the oligo-
mers exhibited any preference for one type of neurite over
the other. HL647Ab40 and HL647Ab42 oligomer binding
densities were respectively 20% and 40% higher on
dendrites than on axons (Fig. S5).
Two groups have recently studied the motion of premade
Ab42 oligomers on live cell membranes (18,34). To study
the motion of neurite-bound oligomers detected here, 10-
frame xyt scans were performed on cultures treated with
1 nMHL647Ab. Kymographs were then assembled to deter-
mine whether oligomers exhibited significant motion over
the 2 min during which the scans were acquired. Oligomers
were sorted into categories based on whether they exhibited
significant motion. Examples of kymographs for oligomers
falling in each category are shown in the SupportingBiophysical Journal 104(4) 894–903
FIGURE 3 On-neurite oligomer size distribution depends on peptide identity and presence of solution peptide. As illustrated in Fig. S7, primary rat hippo-
campal cell cultures were treated with 1 nM HL647Ab40 or 42 for 10 min, and then incubated a further 6, 24, or 48 h in media containing no Ab (washout
plots, shown at left), or containing 1 nM Ab (1 nM plots, shown at right). Results are plotted as proportion of total peptide present as oligomers of each size.
Percentages were calculated from totals from two separate experiments, 30 images per experiment. Each sample contains at least 450 peptide subunits present
in a minimum of 250 oligomers (see the Supporting Material, for exact numbers). Error bars represent standard error of the percentage.
898 Johnson et al.Material (Fig. S6). Overall, 60% to 70% of particles did not
exhibit detectable motion over the course of 10 scans. This
value is consistent with the proportion of cell-bound oligo-
mers exhibiting highly confined motion (motion on a spatial
and temporal scale that would not be detectable with 10
sequential xyt scans) observed in a recent single-particle
tracking study of Ab42 on SH-SY5Y cells (52% to 77%,
depending on type of oligomer) (34).Neurite-bound oligomer size dynamics depend on
peptide identity and solution peptide content
To study the kinetics of neurite-bound oligomer growth and
dissociation, we obtained oligomer size distributions at
several time points during incubations with or without
peptide in solution. Cultures were incubated with 1 nM
HL647Ab40 or HL647Ab42 for 10 min and then further
incubated for up to another 48 h in the presence or absence
of HL647Ab40 or HL647Ab42 (Fig. S7). On-neurite olig-
omer size distributions were then plotted for each treatment
condition. Example images from the 48 h time points are
shown in Fig. S3.
Examination of these results reveals trends in the distri-
bution of oligomer sizes over time. In particular, for
HL647Ab40, there is an observable increase in the propor-
tion of total Ab peptide present as monomer and dimer in
samples incubated in the absence of peptide (washoutBiophysical Journal 104(4) 894–903samples in top left plot, Fig. 3). For HL647Ab42,
this increase is restricted to monomers, and a decrease in
the proportion of peptide present as trimers is also
observed (top right plot, Fig. 3). For both peptides, the
raw oligomer size distributions shift significantly toward
smaller oligomers after 48 h incubation without peptide
in solution, as compared to the distributions following
initial exposure (Mann-Whitney U test, p < 0.0005
for Ab40, p < 0.00001 for Ab42). Average oligomer sizes
changed from 2.2 to 1.9 peptide subunits for HL647Ab40
and from 1.9 to 1.5 peptide subunits for HL647Ab42.
When neurites are continuously incubated with 1 nM
HL647Ab40, the size distribution exhibits no significant
change over time (bottom left plot, Fig. 3). For neurites
continuously exposed to 1 nM HL647Ab42, very subtle
decreases in the proportion of peptide present as monomer
and dimer reflect increases in the proportion present in
tetramers and hexamers and greater. Indeed, a small but
significant shift toward larger oligomers is present in the
Ab42 raw oligomer size distribution after 48 h with
1 nM peptide as compared to at 0 h (immediately
following initial exposure) (Mann-Whitney U test, p <
0.005). The average Ab42 oligomer size changes from
1.9 to 2.0 peptide subunits. Of importance, raw numbers
of monomers and dimers present on the neurites are not
significantly decreased in either sample, following 6 to
48 h incubation at 1 nM (Fig. S5).
FIGURE 4 Oligomers formed from a 1:1 mix of Ab40:Ab42 exhibit
more significant growth. Distributions are shown as percentage of total
monomer present as oligomer of each size. The top plot represents size
distributions for mixed oligomers nonspecifically bound to slides or bound
to primary rat hippocampal neurites. Percentages were calculated from
totals from three separate experiments for neurite-bound and two separate
experiments for slide-bound oligomers, 15 to 20 images per experiment.
Middle and bottom plots show evolution of oligomer size distributions
over up to 48 h. Samples were treated as in Fig. 3. Percentages were calcu-
lated from totals from two separate experiments, 30 images per experiment.
Each sample contains at least 1400 peptide subunits present in a minimum
of 600 particles (see Supporting Material for exact numbers). Error bars
represent standard error of the percentage.
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Ab42 and Ab40 in oligomer formation and toxicity has
increased, due to reports that AD development may depend
sensitively on the ratio of the two peptides in the brain.
Familial AD-associated mutations in presenilins 1 and 2
significantly increase the Ab42:Ab40 ratio in transfected
cultured cells and transgenic mice (35–37), and a higher
Ab42:Ab40 ratio is correlated with earlier age-of-onset in
humans with these mutations (38,39). To determine whether
membrane-bound Ab oligomer evolution is affected by
increases in Ab42:Ab40 ratio, we premixed HL647Ab42
and HL647Ab40 and performed single-molecule oligomer
size measurements on neurite-bound oligomers formed
from the mixture. As the exact Ab42:Ab40 ratio reported
in the literature for FAD mutations varies widely, Ab42
and Ab40 were mixed at a 1:1 ratio.
Interestingly, comparison of raw oligomer size distribu-
tions reveals that neurite-bound oligomers detected after
10 min exposure to this mixture at 1 nM (shown in
Fig. S3) were significantly smaller overall than those de-
tected on neurites incubated with either peptide alone,
with an average size of 1.6 peptide subunits (Mann-Whitney
U-test, p < 0.00001 for both 1:1 Mix versus Ab40 and 1:1
Mix versus Ab42). For mixed on-neurite oligomers, 80%
of the peptide shows up in the monomer-dimer populations
(Fig. 4). In contrast, when present alone, only 50% and 66%
of HL647Ab40 and 42, respectively, are present as mono-
mer-dimers (Fig. 2). This result is not unexpected, given
that Ab40 and Ab42 have been shown to inhibit each other’s
oligomerization in solution, albeit at higher concentrations
than used here (40). Perhaps more surprisingly, the raw olig-
omer size distribution of mixed oligomers observed on the
slides (with an average oligomer size of 1.9 peptide
subunits) is significantly shifted toward larger oligomers
as compared to what is seen for either peptide alone
(Mann-Whitney U-test, p < 0.00001). This may indicate
that, conversely to the results obtained by Murray and
colleagues at micromolar concentrations, the Ab42:Ab40
pair dimerizes and forms larger oligomers more easily
than Ab40:Ab40 or Ab42:Ab42 at low nanomolar levels.
Alternately, the interaction with the poly-D-lysine coated
coverslip may facilitate oligomerization of the mixed
peptide more so than it does for Ab40 or Ab42 individually.
To determine how mixing of the two peptides affects on-
membrane oligomerization, neurites were treated with 1 nM
of the 1:1 mix for 10 min, and oligomer size distributions
were obtained after further incubations of 24 and 48 h,
with and without the peptide in solution (Fig. 4). In contrast
to the data with either peptide alone, in samples incubated
following peptide washout the proportion of peptide present
as monomers decreases by 24 to 48 h. This results in slight
increases in the proportion of peptide subunits present as
dimers, trimers, and tetramers. Comparison of the raw distri-
butions reveals that on-membrane oligomers of the 1:1 mix
grow significantly over 48 h as compared to the 0 h sampleeven in the absence (or in the presence of exceedingly low
concentrations) of solution peptide (Mann-Whitney U-test,
p < 0.00001). Oligomers in the washout 1:1 mixed sample
had an average size of 1.9 peptide subunits.
For neurites incubated in the continued presence of 1 nM
1:1 mixed Ab42:Ab40, a very substantial shift toward larger
oligomers occurs within 24 to 48 h. The proportion of total
peptide present as monomer decreases by roughly 30
percentage points within 24 h, and the proportion present
as dimer decreases by 20 percentage points (bottom plot,
Fig. 4). Interestingly, for the 1:1 mixed peptide, the drop
in proportion of total peptide present as monomer is in
part due to a drop in the raw number of monomers present
on the neurites over time (Fig. S8). These large decreases
in the proportion of peptide contained in small oligomers
translate to large increases in the peptide present as trimers
through heptamers and larger oligomers, with a significantBiophysical Journal 104(4) 894–903
FIGURE 5 Total numbers of peptide subunits bound to neurites over time
depend on peptide identity and presence of solution peptide. The upper plot
depicts the raw number of monomeric subunits on neurites at 24 h and 48 h
following an initial 10 min incubation. Bars labeled with WO represent
washout samples incubated without peptide in the media; bars labeled @
900 Johnson et al.increase in size for the 48 h sample as compared to the 0 h
sample (Mann-Whitney U-test, p < 0.00001). Average olig-
omer size shifts from the previously mentioned 1.6 peptide
subunits to 2.9 peptide subunits. Mixture of the two peptides
at a 1:1 ratio thus has a large impact on oligomer size on the
neurite membrane, inducing greater growth over the hours
to days following initial exposure.
The data presented thus far do not directly indicate that
individual oligomers formed from the 1:1 mixed peptide
contain both HL647Ab42 and HL647Ab40. However, this
is the most plausible explanation for the strong effects of
mixing on the on-membrane oligomerization kinetics
observed here. Recent surface plasmon resonance experi-
ments have indicated that Ab40 and Ab42 bind to each
other, albeit more weakly than either peptide self-associates
(41). In the same study, Ab40 was shown to slow Ab42 fibril
formation, such that fibrillization proceeded at the same rate
for both peptides in a 1:1 mix of the two. These results were
interpreted as strong evidence for formation of mixed fibrils.
Another group also recently showed that incubating Ab40 at
a 1:1 ratio with Ab42 inhibits Ab42 fibril formation, but the
authors of the study explicitly state that formation of high-
order prefibrillar structures is not slowed (42). To test
whether combined Ab40 and Ab42 oligomer (mixed olig-
omer) formation can occur, we performed FRET (fluores-
cence resonance energy transfer) experiments using
neurites treated with HL555Ab40 and HL647Ab42. To
obtain sufficient signal, neurons were incubated with
2 nM HL555Ab40 and 2 nM HL647Ab42 for 10 min. We
do observe FRET signal between the two peptides within
neurite-bound oligomers (Fig. S9). Further exploration
into the exact Ab40:Ab42 stoichiometry of such mixed olig-
omers is in progress (Chang, C., manuscript in preparation).1 nM represent samples incubated with 1 nM peptide in the media. The
images below illustrate the density of oligomers of a 1:1 mix on slides
immediately after a 10 min incubation, at 48 h following peptide washout,
and after 48 h in 1 nM peptide. Scale bar, 5 mm.Total quantities of peptide bound over time
depend on peptide identity
To form a scheme that is consistent with our observations, it
is helpful to examine the total quantities of peptide bound to
the neurites at each time point. Interestingly, the total
quantity of peptide bound after a 10 min incubation at
1 nM is similar under all three conditions (Fig. 5). Following
washout or at 1 nM Ab incubation conditions, HL647Ab40
and HL647Ab42 total peptide follow similar trends: total
neurite-bound peptide decreases over time when no peptide
is present in solution and increases slightly on incubation
with 1 nM Ab. The 1:1 mix of the two peptides, however,
shows a much larger increase in total peptide bound on incu-
bation with 1 nM Ab. This substantial increase in the total
amount of peptide bound likely contributes strongly to the
oligomer growth observed in the 1:1 samples at 1 nM over
48 h (Fig. 4, lowest plot).
Paradoxically, an increase in total peptide bound is also
observed when no peptide is present in solution. This is
most likely because, as shown in the example images inBiophysical Journal 104(4) 894–903the lower section of Fig. 5, ~50% of the slide-bound 1:1
HL647Ab40:42 oligomers are lost after 24 to 48 h incuba-
tion without peptide in solution. This peptide is then avail-
able for binding to the membrane and membrane bound
oligomers. Similar decreases in slide-bound oligomer
density are noted for both HL647Ab40 and HL647Ab42
alone, but the on-slide oligomer density is lower for each
of these (20 5 5 oligomers per frame for HL647Ab40
and 44 5 4 oligomers per frame for HL647Ab42, versus
64 5 2 oligomers per frame for the mixed peptide).
Assuming that half the slide-bound peptide dissociates
into solution results in an estimated postwashout concentra-
tion of ~2 fM 1:1 HL647Ab40:42. The binding affinity of
the 1:1 mixed oligomers for the membrane would have to
be extremely high for the neurites to bind additional peptide
under these conditions. However, the 1:1 mixed oligomers
appear to aggregate rapidly enough on the membrane to
Ab Oligomer Growth on Neuronal Processes 901reduce the overall number of neurite-bound monomers over
time, possibly opening up monomer binding sites to solution
peptide. Additionally, possibly due to their increased size,
oligomers formed from 1:1 HL647Ab40:42 may have
unique effects on the neurite membrane composition which
increase the Ab-membrane affinity (enrichment in external-
ized phosphatidylserine, for instance).FIGURE 6 Binding and on-membrane oligomerization kinetics depend
on peptide identity. A model is proposed to explain observed oligomer
interactions with neurite membranes. Kd1, dissociation constant for initial
binding to membrane; Kd2, dissociation constant for on-membrane oligo-
merization; kon, rate constant for binding of small oligomers to membrane;
koff, rate constant for dissociation of small oligomers from membrane; kolig,
rate constant for on-membrane oligomerization; kdeol, rate constant for
deoligomerization (a group of processes including dissociation of large
oligomers into small ones, dissociation of oligomers from the membrane,
and cellular clearance of membrane-bound oligomers). Small 1:1 mixed
oligomers may bind more tightly to membranes than oligomers of either
peptide alone and grow more slowly. However, once larger oligomers of
the 1:1 mix form, they may be more stable (or less easily cleared by the
cell) than oligomers of either peptide alone.DISCUSSION
Our previous work showed that Ab40 dissolved in media or
buffers containing physiological salts forms oligomers up to
hexamers in size on glass surfaces from the mixture of
monomers and dimers initially present in freshly solubilized
peptide (27). In the current study, this result is reproduced
with both Ab40 and Ab42 (Fig. S1 and Fig. 2, black
bars). Mixed peptide forms smaller oligomers on neurites
and larger ones on the slide, whereas either peptide alone
forms larger neurite-bound oligomers than it forms on the
slide. This result shows that oligomerization on glass
surfaces in media or physiological buffer proceeds along
a distinct pathway as compared to that on membranes.
Although neurite membrane appears to accelerate the
formation of larger oligomers (or selectively bind larger
oligomers) for each peptide individually, it initially associ-
ates with smaller oligomers of the 1:1 mix. However, the
total initial quantities of all three peptide combinations
bound following 10 min incubation at 1 nM Ab are equiva-
lent within experimental error. A kinetic model can be
proposed to explain these results. A possible schema for
oligomers’ interactions with membranes is shown in
Fig. 6. Although this mechanism is likely oversimplified,
it is nevertheless useful in interpreting our observations.
Exact rate constants for these processes remain unknown,
but the data presented here can be used to assemble a quali-
tative model in which the identity of the peptide controls the
rate and quantity of binding. On the basis of our results, we
hypothesize that monomers and dimers of the peptides may
bind to the neurites at the same initial rate (kon) but may
have dissociation rates (koff), oligomer growth rates (kolig),
and large oligomer clearance/dissociation rates (kdeol)
dependent upon the peptide identity.
On-neurite oligomer growth may proceed very rapidly for
Ab40 (high kolig), so that within minutes the neurite-bound
oligomers reach stable sizes. This would explain why little
growth occurs between initial exposure and the 48 h time
point (Fig. 3, lower left plot). For Ab42, growth may also
proceed rapidly, but after the initial phase of rapid formation
of larger oligomers, additional slow oligomer growth may
continue (Fig. 3, lower right plot). The initial smaller size
and the large degree of growth of the mixed oligomers
over 48 h could be explained if formation of larger oligo-
mers on the membrane were much slower for the mixed
peptide than for either Ab42 or Ab40 alone (lower kolig).
In light of recent evidence that neuroblastoma cells caninternalize single Ab oligomers (34), the increased size
observed for the mixed oligomers after 24 to 48 h may
also indicate that the cell’s ability to clear large mixed olig-
omers is reduced as compared to its ability to clear homoge-
neous aggregates of either peptide (lower kdeol for mixed
peptide than for Ab40 or Ab42). Of importance, as FRET
can be observed between Ab40 and Ab42 on neurites
(Fig. S9), a substantial portion of oligomers in the mixed
sample likely contain both peptides. These observations
have important implications for AD. FAD-associated muta-
tions in presenilins 1 and 2 significantly increase Ab42:
Ab40 ratio in transfected cultured cells and transgenic
mice (35–37), and higher Ab42:Ab40 ratio is correlated
with earlier age-of-onset in humans with these mutations
(38,39).
In a number of preliminary experiments, we did not
observe grossly apparent toxicity in cells treated for up to
48 h with Ab concentrations in the 1 to 10 nM range. There-
fore, understanding the time evolution of the functional
effects of these oligomers will require further study. Jan
and colleagues (42) observed higher viability levels in rat
cortical neurons treated with a 1:1 mix of initially mono-
meric Ab40 and Ab42 as compared with cells treated with
equimolar amounts of either peptide alone. This study
was, however, performed at 10 mM peptide (10,000 times
the level used here) and did not assess subtle measures of
neurophysiology. More recently, Kuperstein et al. (43)Biophysical Journal 104(4) 894–903
902 Johnson et al.treated neurons with 1 mM peptide for only 2 h and demon-
strated that under these conditions, a 3:7 ratio of Ab42/
Ab40 reduced the neuronal firing rate to a greater degree
than Ab42 alone. If oligomer neurotoxicity or modulation
of synaptic function increase with oligomer size, as some
have suggested (44,45), the current results might help
explain the observations of Kuperstein and colleagues.
We did not observe initial binding of Ab40 or Ab42 at
low nanomolar concentrations to be synaptically localized
(Fig. S4), and on-neurite oligomers are only slightly more
densely distributed on dendrites than on axons after
a 10 min exposure (Fig. S5). A difference of the magnitude
observed here could be due to differences in membrane
composition or to higher density of Ab receptor proteins
on dendrites. Although a number of studies have reported
that Ab preferentially binds to synapses (18,30,31), these
have all to our knowledge either used preaggregated oligo-
mers or stained for endogenous oligomers in model mice
using an antioligomer antibody. These studies may there-
fore have overlooked low-molecular weight oligomers
formed in contact with the membrane, the behavior of
which is the focus of the current work. The oligomers
described here may represent precursor structures to preag-
gregated oligomers or a structurally distinct set of Ab
aggregates that can only form in contact with neuronal
membranes. We note, however, that confocal mode kymo-
graphs (Fig. S6) identified a small portion of neurite-bound
oligomers which are mobile (20% to 30%). Migration of
these oligomers to cell membrane regions containing
specific receptors or even to synapses could occur given
sufficient time.CONCLUSIONS
In the work presented here, a single-molecule microscopy
method was applied to identify and characterize fluores-
cently labeled Ab oligomers on the neurites of living cells
and to follow their time evolution. The results point to
a mechanism by which, at physiological concentrations,
very small Ab oligomers bind to the membrane and grow
on the membrane over time, with kinetics dependent upon
the local Ab42:Ab40 ratio. Such oligomers may gradually
localize to synapses and interfere with function of specific
membrane proteins or aggregate further to directly form
toxic pores in biological membranes. Recent work in our
laboratory has demonstrated that Ab40 oligomers must
contain at least six monomeric subunits to induce significant
conductivity in model membranes (28). The quantities of
such structures observed on the timescales examined here
are minimal and probably result in only subtle changes
to neuronal function. These results provide new, to our
knowledge, insight into the dynamics and mechanism of
Ab binding and oligomer formation on membranes at phys-
iological concentrations. They also provide a foundation for
future studies into the time, concentration, and Ab42:Ab40Biophysical Journal 104(4) 894–903ratio dependence of oligomer growth and the correlation of
these factors with neurotoxicity.SUPPORTING MATERIAL
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